The new registration delivers exceptional and long-lasting control of leaf diseases in cereals
Calgary, AB (April 3, 2019) - Today Bayer announced that Delaro® fungicide is now approved for use in cereals and will be available in Western Canada for the 2019 growing season. Already a trusted fungicide for peas, lentils, chickpeas and soybeans, the label expansion of Delaro provides cereal growers with exceptional and long-lasting control of foliar diseases.
“Since entering the Canadian market in 2014, Delaro has set high standards in pulse and soybean disease control,” says Troy Basaraba, Market Development Agronomist at Bayer. “The label expansion means this valuable tool is now able to give growers more of the same in cereals.”
Delaro combines two dynamic and complementary active ingredients, prothioconazole (Group 3) and trifloxystrobin (Group 11) for dual modes of action to provide quick and long lasting disease protection. In cereals, Delaro provides exceptional control of important foliar diseases including septoria leaf blotch, tan spot, rust species, net and spot blotch, scald and more.
For optimum control of labelled leaf and stem diseases, cereal growers should apply Delaro at early flag leaf, and before the head starts to emerge from the boot. A follow-up application with Prosaro® XTR fungicide is recommended at head timing for fusarium head-blight protection and comprehensive foliar disease management.
For more information regarding Delaro, growers are encouraged to talk to their local retailers or visit cropscience.bayer.ca/Delaro.
Always read and follow label directions. Delaro and Prosaro XTR are registered trademarks of the Bayer Group. © 2019 Bayer CropScience Inc. All rights reserved.
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2018, the Group employed around 117,000 people and had sales of 39.6 billion euros. Capital expenditures amounted to 2.6 billion euros, R&D expenses to 5.2 billion euros. For more information, go to www.bayer.ca.